IRIS Accounts Production v25.2.0.378 07456543 director 1.1.24 31.12.24 31.12.24 false true false false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074565432023-12-31074565432024-12-31074565432024-01-012024-12-31074565432022-12-31074565432023-01-012023-12-31074565432023-12-3107456543ns15:EnglandWales2024-01-012024-12-3107456543ns14:PoundSterling2024-01-012024-12-3107456543ns10:Director12024-01-012024-12-3107456543ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107456543ns10:SmallEntities2024-01-012024-12-3107456543ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3107456543ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107456543ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107456543ns10:FullAccounts2024-01-012024-12-310745654312024-01-012024-12-3107456543ns10:RegisteredOffice2024-01-012024-12-3107456543ns5:CurrentFinancialInstruments2024-12-3107456543ns5:CurrentFinancialInstruments2023-12-3107456543ns5:ShareCapital2024-12-3107456543ns5:ShareCapital2023-12-3107456543ns5:FurtherSpecificReserve3ComponentTotalEquity2024-12-3107456543ns5:FurtherSpecificReserve3ComponentTotalEquity2023-12-3107456543ns5:RetainedEarningsAccumulatedLosses2024-12-3107456543ns5:RetainedEarningsAccumulatedLosses2023-12-3107456543ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107456543ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3107456543ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3107456543ns5:PatentsTrademarksLicencesConcessionsSimilar2024-12-3107456543ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-3107456543ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107456543ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3107456543ns5:FurtherSpecificReserve3ComponentTotalEquity2023-12-3107456543ns10:Director112023-12-3107456543ns10:Director112022-12-3107456543ns10:Director112024-01-012024-12-3107456543ns10:Director112023-01-012023-12-3107456543ns10:Director112024-12-3107456543ns10:Director112023-12-31
REGISTERED NUMBER: 07456543 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

MEDSTROM FINANCE LTD

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEDSTROM FINANCE LTD

COMPANY INFORMATION
for the year ended 31 December 2024







DIRECTOR: Mr D B G Belli





REGISTERED OFFICE: 2 Cygnus Court
Beverley Road
Pegasus Business Park
Castle Donnington
Derbyshire
LE74 2SA





REGISTERED NUMBER: 07456543 (England and Wales)





ACCOUNTANTS: Magma Audit LLP
Unit 2 Charnwood Edge Business Park
Syston Road, Leicester
LE7 4UZ
Magma Audit LLP is part
Of the Dains Group

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

BALANCE SHEET
31 December 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 7,500 11,250
Investment property 5 725,000 800,000
732,500 811,250

CURRENT ASSETS
Debtors 6 1,123 10,773
Cash at bank 8,443 9,198
9,566 19,971
CREDITORS
Amounts falling due within one year 7 (2,080 ) (1,920 )
NET CURRENT ASSETS 7,486 18,051
TOTAL ASSETS LESS CURRENT
LIABILITIES

739,986

829,301

PROVISIONS FOR LIABILITIES (6,000 ) (24,750 )
NET ASSETS 733,986 804,551

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

BALANCE SHEET - continued
31 December 2024

2024 2023
Notes £    £   

CAPITAL AND RESERVES
Called up share capital 20 20
Fair value reserve 8 60,320 135,320
Retained earnings 673,646 669,211
733,986 804,551

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 September 2025 and were signed by:





Mr D B G Belli - Director


MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024


1. STATUTORY INFORMATION

Medstrom Finance Ltd is a limited company, registered in England and Wales. Its registered office address is 2 Cygnus Court, Beverley Road, Pegasus Business Park, Castle Donnington, Derbyshire, LE74 2SA and the registered number is 07456543.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The presentation currency of the financial statements is the Pound Sterling (£), and figures are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.


Turnover
Turnover is derived from the trade of goods and is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Rendering of goods

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

- the amount of revenue can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Debenture loans are being amortised evenly over their estimated useful life of eight years.

Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. The surplus or deficit on revaluation is recognised within the revaluation reserve.

Where fair value cannot be achieved without undue cost or effort, investment property is accounted for as tangible fixed assets.

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
(i) Financial assets

Basic financial assets, including trade and other debtors, cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest rate method.

(ii) Financial liabilities

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Taxation
The tax expense for the year comprises current and deferred tax.

Tax is recognised in profit or loss except that a change attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and

- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Cash and cash equivalents
Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Debenture
loan
£   
COST
At 1 January 2024
and 31 December 2024 30,000
AMORTISATION
At 1 January 2024 18,750
Amortisation for year 3,750
At 31 December 2024 22,500
NET BOOK VALUE
At 31 December 2024 7,500
At 31 December 2023 11,250

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2024


5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 January 2024 800,000
Revaluations (75,000 )
At 31 December 2024 725,000
NET BOOK VALUE
At 31 December 2024 725,000
At 31 December 2023 800,000

The fair value of the investment property has been arrived at on the basis of a valuation carried out by a Director.

Fair value at 31 December 2024 is represented by:
£   
Valuation in 2021 135,320
Valuation in 2024 (75,000 )
Cost 664,680
725,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 790 2,063
Directors' current accounts 333 8,441
VAT - 269
1,123 10,773

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 160 -
Accruals and deferred income 1,920 1,920
2,080 1,920

8. RESERVES
Fair
value
reserve
£   
At 1 January 2024 135,320
Revaluation (75,000 )

At 31 December 2024 60,320

MEDSTROM FINANCE LTD (REGISTERED NUMBER: 07456543)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2024


9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
Mr D B G Belli
Balance outstanding at start of year 8,441 (77 )
Amounts advanced 19,764 37,874
Amounts repaid (27,872 ) (29,356 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 333 8,441